December

• December 24, 2008
• NEW INDICATION FOR FAST-ACTING POSTPRANDIAL HYPOGLICEMIC AGENT FASTIC^®TABLET / STARSIS^®TABLET WAS APPROVED FOR COMBINATION THERAPY WITH THIAZOLIDINES

• December 15, 2008
• Notice of Completion of Acquisition of Treasury Stock

• December 3, 2008
• Presentation material for the press conference held on December 3, 2008 (pdf 1.24MB)

November

• November 20, 2008
• Astellas Announces the Outcome of FDA's Advisory Committee in the US for Telavancin

• November 18, 2008
• Astellas Establishes a Marketing Subsidiary in India

• November 5, 2008
• Astellas Announces Acquisition of Treasury Stock

October

• October 27, 2008
• Astellas Launches the Immunosuppressant Graceptor^®in Japan

• October 24, 2008
• Astellas Announces the Withdrawal of EU MAA for Telavancin for Complicated Skin and Soft Tissue Infections

• October 6, 2008
• Astellas Launches Irribow^® for the Treatment of Irritable Bowel Syndrome

• October 1, 2008
• Astellas Completes the New Buildings in its Tsukuba

• October 1, 2008
• Dissolution of the European Subsidiary Fujisawa Ireland Ltd.

September

• September 30, 2008
• Astellas Submits an sNDA for the immunosuppressant Prograf^® for Myasthenia Gravis in Japan (pdf 16KB)

• September 19, 2008
• Maxygen and Astellas Announce Global Agreement to Develop New Therapies for Autoimmune Diseases and Transplantation (pdf 28KB)

• September 16, 2008
• Contents of Stock Acquisition Rights (Stock Option Scheme as Stock-Linked Compensation Plan) (pdf 32KB)

• September 4, 2008
• Astellas and APP Pharmaceuticals Announce Transfer of the Grand Island Plant (pdf 20KB)

August

• August 29, 2008
• Allotment of Stock Acquisition Rights (Stock Option Scheme as Stock-Linked Compensation Plan) (pdf 58KB)

• August 22, 2008
• Notice of Completion of Acquisition of Treasury Stock (pdf 24KB)

• August 15, 2008
• Notice of the Result of Acquisition of Treasury Stock through ToSTNeT-3 (pdf 28KB)

• August 14, 2008
• Notice of Acquisition of Treasury Stock through ToSTNeT-3 (pdf 25KB)

• August 13, 2008
• Cardiome and Astellas Announce Receipt of FDA Approvable Letter for KYNAPID (pdf 89KB)

• August 1, 2008
• Astellas Announces Acquisition of Treasury Stock (pdf 45KB)

• August 1, 2008
• Astellas Launches the Candin Antifungal Agent Mycamine^® in the UK (pdf 94KB)

July

• July 22, 2008
• ASTELLAS AND BOEHRINGER FILED LAWSUIT AGAINST FLOMAX^® GENERIC FOR PATENT INFRINGEMENT IN THE US (pdf 28KB)

• July 17, 2008
• Astellas Receives a Japanese Marketing Approval for Irribow^® (pdf 75KB)

• July 17, 2008
• Astellas Receives a Japanese Marketing Approval for the Immunosuppressant Graceptor^® (pdf 23KB)

June

• June 25, 2008
• ASTELLAS LAUNCHES LEXISCAN(tm) (REGADENOSON) INJECTION FOR USE AS A PHARMACOLOGIC STRESS AGENT IN RADIONUCLIDE MYOCARDIAL PERFUSION IMAGING (MPI) (pdf 27KB)

• June 24, 2008
• New strength added to fluvoxamine maleate, 75mg tablets launched (pdf 30KB)

• June 23, 2008
• Notice of Completion of Acquisition of Treasury Shares (pdf 24KB)

• June 23, 2008
• Submit an sNDA for the immunosuppressant Prograf^® for Ulcerative Colitis in Japan (pdf 15KB)

• June 20, 2008
• Astellas to Support Relief Efforts following Iwate-Miyagi Inland Earthquake (pdf 29KB)

May

• May 16, 2008
• Astellas to Support Relief Efforts following China Earthquake (pdf 29KB)

• May 13, 2008
• Astellas Announces Acquisition of Treasury Stocks (pdf 45KB)

• May 13, 2008
• Astellas Announces Cancellation of Treasury Stocks (pdf 31KB)

• May 13, 2008
• Issuance of Stock Acquisition Rights for Stock Option Scheme as Stock-Linked Compensation Plan (pdf 55KB)

• May 7, 2008
• Mycamine^® Has Now Been Approved in Europe (pdf 94KB)

• May 7, 2008
• Astellas Receives an Approvable Letter for an Immunosuppressant FK506 Modified Release Formulation in the U.S. (pdf 46KB)

April

• April 25, 2008
• Astellas and CoMentis Sign Agreement to Collaborate on the Research, Development and Commercialization of Beta-Secretase Inhibitors (pdf 32KB)

• April 24, 2008
• Change of Representative Directors (pdf 31KB)

• April 11, 2008
• CV Therapeutics and Astellas Announce FDA Approval for Lexiscan(TM) (regadenoson) Injection (pdf 23KB)

• April 2, 2008
• The FDA Accepts the Complete Response for Clinical Holds of FG-2216*/FG-4592 for the Treatment of Anemia (pdf 34KB)

March

• March 14, 2008
• Astellas Receives an Approvable Letter for Their Immunosuppressant FK506 Modified Release Formulation in the U.S. (pdf 48KB)

• March 10, 2008
• Conclusion of Co-Development and Co-Marketing Agreement on a Functional Dyspepsia Agent Z-338/YM443 in Japan with Zeria (pdf 28KB)

• March 5, 2008
• Astellas Reaches Settlement Agreement with Taiyo on the Oral Cephalosporin Antibiotic Cefzon^® Litigations (pdf 30KB)

• March 4, 2008
• Astellas Announces Global Management System and Establishes Global Development Functional Headquarters (pdf 53KB)

February

• February 22, 2008
• Astellas Receives a Positive CHMP Opinion for EU Marketing Authorization for Mycamine^® (pdf 50KB)

• February 1, 2008
• Astellas Announces Revision of Dividend Forecast for FY2007 (3rd Company Fiscal Period) (pdf 25KB)

January

• January 23, 2008
• FDA APPROVES ADDITIONAL INDICATION FOR ASTELLAS´ MYCAMINE^® (pdf 37KB)

• January 21, 2008
• Notice of Completion of Acquisition of Treasury Shares (pdf 24KB)

---

• Message
• Business Philosophy
• VISION 2015
• CSR-Based Management
• Governance & Internal Control
• Business Activities
• Corporate Profile
• Disclosure Policy
• News Release
  • 2010
  • 2009
  • 2008
  • Past news
  • Yamanouchi
  • Fujisawa